GB0124032D0 - Protein - Google Patents

Protein

Info

Publication number
GB0124032D0
GB0124032D0 GBGB0124032.4A GB0124032A GB0124032D0 GB 0124032 D0 GB0124032 D0 GB 0124032D0 GB 0124032 A GB0124032 A GB 0124032A GB 0124032 D0 GB0124032 D0 GB 0124032D0
Authority
GB
United Kingdom
Prior art keywords
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0124032.4A
Other versions
GB2371303A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of GB0124032D0 publication Critical patent/GB0124032D0/en
Publication of GB2371303A publication Critical patent/GB2371303A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
GB0124032A 2000-10-05 2001-10-05 Receptor polypeptides with immunomodulatory activity Withdrawn GB2371303A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0024446.7A GB0024446D0 (en) 2000-10-05 2000-10-05 Protein

Publications (2)

Publication Number Publication Date
GB0124032D0 true GB0124032D0 (en) 2001-11-28
GB2371303A GB2371303A (en) 2002-07-24

Family

ID=9900755

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0024446.7A Ceased GB0024446D0 (en) 2000-10-05 2000-10-05 Protein
GB0124032A Withdrawn GB2371303A (en) 2000-10-05 2001-10-05 Receptor polypeptides with immunomodulatory activity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0024446.7A Ceased GB0024446D0 (en) 2000-10-05 2000-10-05 Protein

Country Status (1)

Country Link
GB (2) GB0024446D0 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (en) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid β (1-42) oligomers, process for their preparation and their use
RU2432362C2 (en) 2005-11-30 2011-10-27 Эбботт Лэборетриз Monoclonal antibodies and applications thereof
DK1954718T3 (en) 2005-11-30 2014-12-15 Abbvie Inc Anti-A-globulomer antibodies antigenbindingsgrupper thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods for producing said antibodies,
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
MX336196B (en) 2010-04-15 2016-01-11 Abbvie Inc Amyloid-beta binding proteins.
MX358739B (en) 2010-08-14 2018-09-03 Abbvie Inc Star Amyloid-beta binding proteins.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2734600A (en) * 1999-01-21 2000-08-07 Millennium Pharmaceuticals, Inc. 17723 receptor, a g-protein coupled receptor
EP1325030A2 (en) * 2000-03-29 2003-07-09 Novartis AG Genes isolated from dendritic cells, gene products and methods employing the same

Also Published As

Publication number Publication date
GB0024446D0 (en) 2000-11-22
GB2371303A (en) 2002-07-24

Similar Documents

Publication Publication Date Title
GB0001704D0 (en) Protein
GB0003079D0 (en) Novel protein
GB0011185D0 (en) Protein
GB0124032D0 (en) Protein
GB0027905D0 (en) New protein
GB0009181D0 (en) Protein
GB0025677D0 (en) New protein
IL150774A0 (en) Apoptin-associating protein
EP1323734A4 (en) Irap-binding protein
EP1179592A4 (en) Proteins nectin-3
GB0119929D0 (en) Protein
GB0008549D0 (en) Protein
GB0001700D0 (en) Novel protein
GB0001709D0 (en) Protein
GB0015307D0 (en) Protein
GB0011056D0 (en) Protein
GB0008774D0 (en) Protein
GB0030186D0 (en) Protein
GB0031341D0 (en) Protein
GB0014825D0 (en) Protein
GB0030294D0 (en) Protein
GB0001708D0 (en) Protein
GB0027308D0 (en) Drug-activated proteins
GB0128025D0 (en) New protein
GB0010596D0 (en) New protein

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)